Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Dec 2018

Tandy-Connor Stephany, Guiltinan Jenna, Krempely Kate, LaDuca Holly, Reineke Patrick, Gutierrez Stephanie, Gray Phillip, Tippin Davis Brigette

Abstract excerpt

PURPOSE: There is increasing demand from the public for direct-to-consumer (DTC) genetic tests, and the US Food and Drug Administration limits the type of health-related claims DTC tests can market. Some DTC companies provide raw genotyping data to customers if requested, and these raw data may include variants occurring in genes recommended by the American College of Medical Genetics and Genomics to be reported...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Genomics

Share to Internet

Share to United States

Share to United States Food and Drug Administration

Source

Open in PubMed Open full text

Identifiers

PMID: 29565420
DOI: 10.1038/gim.2018.38
PMCID: PMC6301953

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.PMID 29565420Read ↗

Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

Variant classification changes over time in the clinical molecular diagnostic laboratory setting.Semantic proximity Read ↗

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic TestingSemantic proximity Read ↗

The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency.Semantic proximity Read ↗

CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies.Semantic proximity Read ↗

Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository.Semantic proximity Read ↗

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests.Semantic proximity Read ↗

Genomic test validation for incidental findings.Semantic proximity Read ↗

Creation of an Expert Curated Variant List for Clinical Genomic Test Development and Validation: A ClinGen and GeT-RM Collaborative Project.Semantic proximity Read ↗

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.Semantic proximity Read ↗

Assessing the analytical validity of SNP-chips for detecting very rare pathogenic variants: implications for direct-to-consumer genetic testingSemantic proximity Read ↗

Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.